Replies to post #21533 on Mymetics Corp (MYMX)

[bow-tie]

Mucosal antibody response induced with a nasal virosome-based ...
www.researchgate.net/publication/9083511_Mucosal...
N3OASq only significantly increased the cell-mediated immune response. Furthermore, nasal administration of the influenza vaccine in combination with any of the adjuvants; Endocine™, N3OA or ...

https://www.researchgate.net/publication/9083511_Mucosal_antibody_response_induced_with_a_nasal_virosome-based_influenza_vaccine

Mucosal antibody response induced with a nasal virosome-based influenza vaccine
Author links open overlay panelPDurreraUGlückbCSpyraA.BLangaRZurbriggenaCHerzogaRGlücka
a
Berna Biotech Ltd., Research and Development, Rehhagstr. 79, CH-3018 Bern, Switzerland
b
Division of Occupational Medicine, SUVA Swiss National Accident Insurance, CH-6002 Lucerne, Switzerland
https://www.sciencedirect.com/science/article/pii/S0264410X03004572?via%3Dihub

[bow-tie]

STING in Vaccine Adjuvants
https://www.invivogen.com/review-sting-vaccine

LMAO Alum!!! Virosome work 100 times better!!!! :)


This what am talking about!! :)
The STING-TBK1-IRF3 axis has also been involved in the adjuvant activity of c-di-GMP. Cyclic-di-GMP is a bacterial signaling molecule with strong immunostimulatory activity, which is currently being investigated as a mucosal adjuvant [3, 4].

4. Pedersen GK. et al., 2011. Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP. PLoS One. 6(11):e26973.

3. Chen W. et al., 2010. The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine. 28(18):3080-5 (review).